Award

Consolidated Basic Cancer Research Program

Description: PROJECT NARRATIVE – OVERALL Members of the Wistar Cancer Center elucidate the mechanistic underpinning of malignancy, pursue innovative disease models, and identify novel tumor vulnerabilities suitable for therapeutic intervention. Driven by collaboration and partnership, the Wistar Cancer Center delivers on innovative basic and translational cancer research, brings cutting-edge science to the community, trains the next generation of research leaders, and strives to advance its discoveries to the clinic for the benefit of cancer patients and their families.
Funding type: program
Funder scheme: P30
Start date: 1978-09-01
End date: 2026-02-28
Investigator: DARIO C ALTIERI
Institution: WISTAR INSTITUTE
Funded outputs count: 1,902
Funder award ID: P30CA010815
OpenAlex ID: G9000906427
2026 · Laura M. Reynolds, Ryan Lamm, et al. · Molecular Therapy — Nucleic Acids
2026 · Michela Perego, Andrew V. Kossenkov, et al. · Science Advances
2026 · Urvi S. Zankharia, Adam M. Glass, et al. · PLoS Pathogens
2026 · Haiwei Mou, Veronika Yakovishina, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Linlin Yang, Michael J. Hogan, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Lorenzo Serra, Claire M. O’Brien, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Bing-Rui Zhou, Edgar Luzete-Monteiro, et al. · Molecular Cell
2026 · Garry R. Smith, Mark E. McDonnell, et al. · ACS Medicinal Chemistry Letters
2026 · Maria Tsingas, Konstantinos Tsingas, et al. · Cell Death and Disease
2026 · Jayaraju Dheekollu, Coltin J. Albitz, et al. · Cell Reports
2026 · Apoorva Uboveja, Baixue Yang, et al. · Nature · 3
2026 · Andrew T. Milcarek, Minjeong Yeon, et al. · Proceedings of the National Academy of Sciences · 1
2026 · Jamie Bregman, Calen Nichols, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Haiyin Li, Yeqing Chen, et al. · Molecular Cancer · 4
Year
Topic